These numbers cannot determine an individuals life expectancy with lymphoma
Ruhoys first book, Please Support Health Rising and Keep the Information Flowing A large Veterans Administration study, published in March 2025, which followed over 1,000,000 people, including 200,000 diabetic patients, found that GLP-1 agonists (semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), or exenatide (Byetta)) helped in a remarkably wide variety of ways
has received honoraria and travel grants from Astra Zeneca, Eli Lilly, Merck Sharp & Dohme, Novartis, Takeda and Sanofi
Results: Twelve PwT1D (8/12, 66.7% women) with mean (SD) age 65 (2) years, diabetes duration 36 (12) years, BMI 28.1 (4.1) kg/m 2 , HbA1c 7.5 (0.9) % (58 [10] mmol/mol) and time in range 68 (17) % were analysed
Both of these medications have similar safety profiles, but they work in slightly different ways